Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3762206019 | Fluorometholone and sulfacetamide only product in ocular dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3762207011 | Product containing only fluorometholone and sulfacetamide in ocular dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fluorometholone and sulfacetamide only product in ocular dose form | Has manufactured dose form | Ocular dose form (dose form) | true | Inferred relationship | Some | ||
Fluorometholone and sulfacetamide only product in ocular dose form | Is a | Product containing only fluorometholone and sulfacetamide (medicinal product) | true | Inferred relationship | Some | ||
Fluorometholone and sulfacetamide only product in ocular dose form | Is a | Product containing fluorometholone and sulfacetamide in ocular dose form (medicinal product form) | true | Inferred relationship | Some | ||
Fluorometholone and sulfacetamide only product in ocular dose form | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
Fluorometholone and sulfacetamide only product in ocular dose form | Has active ingredient | Sulfacetamide (substance) | true | Inferred relationship | Some | 2 | |
Fluorometholone and sulfacetamide only product in ocular dose form | Has active ingredient | Fluorometholone | true | Inferred relationship | Some | 1 | |
Fluorometholone and sulfacetamide only product in ocular dose form | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | True | Fluorometholone and sulfacetamide only product in ocular dose form | Inferred relationship | Some |
This concept is not in any reference sets